Angelo Di Leo Selected Research

Angelo Di Leo Research Topics

Disease

134	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
55	Neoplasms (Cancer) 11/2021 - 01/2002
7	Circulating Neoplastic Cells 05/2021 - 07/2012
5	Disease Progression 12/2021 - 02/2015
5	Triple Negative Breast Neoplasms 01/2015 - 10/2011
4	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2015
4	Diarrhea 01/2019 - 12/2008
2	Thrombosis (Thrombus) 08/2020 - 11/2006
2	Neutropenia 01/2019 - 11/2017
2	Leukopenia 01/2019 - 11/2017
2	Retinoblastoma (Glioblastoma, Retinal) 07/2018 - 01/2016
2	Hypertension (High Blood Pressure) 01/2018 - 01/2018
2	Exanthema (Rash) 05/2015 - 12/2008
2	Pathologic Complete Response 10/2013 - 05/2012
2	Cardiotoxicity 11/2011 - 01/2009
1	Colorectal Neoplasms (Colorectal Cancer) 06/2021
1	Overweight 10/2020
1	Coronary Stenosis (Coronary Artery Stenosis) 08/2020
1	Myocardial Infarction 08/2020
1	Acute Coronary Syndrome 08/2020
1	Aortic Valve Insufficiency (Aortic Regurgitation) 01/2020
1	Bicuspid Aortic Valve Disease 01/2020
1	Drug-Related Side Effects and Adverse Reactions 12/2019
1	Arthralgia (Joint Pain) 01/2018

Drug/Important Bio-Agent (IBA)

37	Hormones (Hormone)IBA 12/2021 - 02/2011
21	Estrogen ReceptorsIBA 05/2021 - 12/2004
18	Biomarkers (Surrogate Marker)IBA 11/2021 - 03/2008
17	AnthracyclinesIBA 08/2015 - 05/2002
14	Phenobarbital (Luminal)FDA Link 05/2021 - 01/2013
12	Docetaxel (Taxotere)FDA Link 01/2020 - 07/2002
12	Lapatinib (GW572016)FDA Link 03/2016 - 12/2008
11	Trastuzumab (Herceptin)FDA Link 12/2020 - 01/2002
10	Fulvestrant (Faslodex)FDA Link 01/2022 - 10/2010
9	ErbB Receptors (EGF Receptor)IBA 12/2021 - 12/2008
9	human ERBB2 proteinIBA 01/2021 - 12/2008
9	Paclitaxel (Taxol)FDA LinkGeneric 08/2012 - 10/2008
8	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013 - 07/2002
7	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 12/2004
7	Aromatase InhibitorsIBA 10/2020 - 02/2015
7	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2013 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 05/2021 - 10/2002
6	Letrozole (Femara)FDA LinkGeneric 01/2021 - 01/2018
6	palbociclibIBA 01/2021 - 01/2016
6	Fluorouracil (Carac)FDA LinkGeneric 05/2015 - 05/2002
6	trioctyl phosphine oxide (TOPO)IBA 12/2009 - 05/2002
5	Epidermal Growth Factor (EGF)IBA 02/2021 - 10/2014
5	Taxoids (Taxanes)IBA 01/2020 - 01/2009
5	taxaneIBA 07/2015 - 02/2004
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015 - 05/2002
4	Tamoxifen FDA LinkGeneric 01/2020 - 12/2004
4	Cyclin-Dependent Kinase 4IBA 12/2019 - 11/2014
4	ParaffinIBA 01/2019 - 07/2002
4	abemaciclibIBA 01/2019 - 11/2017
4	Methotrexate (Mexate)FDA LinkGeneric 05/2015 - 05/2002
4	Biological ProductsIBA 03/2015 - 01/2009
4	Epirubicin (Ellence)FDA LinkGeneric 10/2013 - 05/2002
3	RNA (Ribonucleic Acid)IBA 11/2021 - 01/2016
3	pertuzumabIBA 01/2021 - 01/2020
3	exemestane (Aromasin)FDA Link 01/2020 - 07/2018
3	Estrogens (Estrogen)FDA Link 02/2018 - 08/2013
2	Protons (Proton)IBA 06/2021 - 03/2017
2	Thymidine KinaseIBA 05/2021 - 01/2020
2	thymidine kinase 1IBA 01/2020 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 01/2010
2	Formaldehyde (Formol)FDA Link 01/2019 - 07/2008
2	Capecitabine (Xeloda)FDA Link 01/2015 - 12/2008
2	Messenger RNA (mRNA)IBA 10/2013 - 12/2008
2	Pharmaceutical PreparationsIBA 07/2012 - 07/2007
2	DNA (Deoxyribonucleic Acid)IBA 07/2012 - 12/2007
2	Cytotoxins (Cytolysins)IBA 12/2009 - 02/2004
2	TubulinIBA 07/2008 - 12/2002
2	tau Proteins (tau Protein)IBA 07/2008 - 12/2002
1	heparanaseIBA 05/2021
1	Circulating Tumor DNAIBA 05/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2020
1	PolymersIBA 08/2020
1	Sirolimus (Rapamycin)FDA Link 08/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	EnzymesIBA 12/2019
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 12/2019
1	LigandsIBA 11/2019
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 10/2019
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019
1	Triptorelin Pamoate (Trelstar)FDA Link 10/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	pembrolizumabIBA 01/2019
1	ThymidineIBA 03/2018
1	NVP-BKM120IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018

Therapy/Procedure

71	Therapeutics 12/2021 - 01/2002
30	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
13	Adjuvant Chemotherapy 11/2019 - 10/2008
3	Neoadjuvant Therapy 07/2018 - 05/2012
3	Radiotherapy 01/2018 - 01/2009
1	Stents 08/2020
1	Drug-Eluting Stents 08/2020
1	Percutaneous Coronary Intervention 08/2020
1	Off-Label Use 01/2020